Breaking News

Trials & Filings in Brief: Nov. 18, 2013

By Gil Roth | November 18, 2013

AbbVie, ChanRx, Enanta, Gilead, Merck, Sanofi

Phase II
ChanRx posts positive A-Fib data . . . read more

Phase III
AbbVie, Enanta show HCV results . . . read more

Gilead gets EC approval for Vitekta . . . read more

Merck's Noxafil IV gets priority review . . . read more

Sanofi ends JAK2 development . . . read more
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.